A Study to Investigate Safety, Tolerability and Pharmacokinetics of REM0045392 Compared With Placebo in Healthy Participants.
Clinical trial NCT07016464 · TERMINATED
Trial details
- NCT number
- NCT07016464
- Sponsor
- reMYND
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-03-20
- Primary completion
- 2025-06-23
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.